Literature DB >> 14969747

Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.

Naibedya Chattopadhyay1, Jacob T-Felt Hansen, Madan M Godbole, Edward M Brown.   

Abstract

Transforming growth factor beta (TGFbeta) and hepatocyte growth factor (HGF) promote glioma progression. Using U87human astrocytoma cells, which express TGFbeta receptors (TbetaRs), we show (1) mRNA expression of Smads (2, 3, 4), bone morphogenetic protein (BMP)- and activin-A receptors; (2) TGFbeta1 inhibits and HGF induces proliferation; (3) TGFbeta1 and activin-A equipotently inhibit HGF secretion more than BMP-2, but none alters c-Met expression. Because interfering with TbetaR signaling might nullify the beneficial inhibition of HGF secretion, activin-A should instead be considered for combination glioma therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14969747     DOI: 10.1016/j.molbrainres.2003.11.008

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Effect of brefelamide on HGF-induced survival of 1321N1 human astrocytoma cells.

Authors:  Shigeyoshi Honma; Sachina Takasaka; Takahiro Ishikawa; Takahiro Shibuya; Satoru Mitazaki; Sumiko Abe; Makoto Yoshida
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-29       Impact factor: 2.416

2.  Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.

Authors:  Katharina Seystahl; Isabel Tritschler; Emese Szabo; Ghazaleh Tabatabai; Michael Weller
Journal:  Neuro Oncol       Date:  2014-08-27       Impact factor: 12.300

3.  Identification of diagnostic serum protein profiles of glioblastoma patients.

Authors:  Anja Elstner; Florian Stockhammer; Trong-Nghia Nguyen-Dobinsky; Quang Long Nguyen; Ingo Pilgermann; Amanjit Gill; Anke Guhr; Tingguo Zhang; Kajetan von Eckardstein; Thomas Picht; Julian Veelken; Robert L Martuza; Andreas von Deimling; Andreas Kurtz
Journal:  J Neurooncol       Date:  2010-07-09       Impact factor: 4.130

4.  Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.

Authors:  Eleanna Papa; Michael Weller; Tobias Weiss; Elisa Ventura; Isabel Burghardt; Emese Szabó
Journal:  Cell Death Dis       Date:  2017-12-13       Impact factor: 8.469

Review 5.  Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

Authors:  Paulo Linhares; Bruno Carvalho; Rui Vaz; Bruno M Costa
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

6.  Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.

Authors:  Liman Niu; Xueling Cui; Yan Qi; Dongxue Xie; Qian Wu; Xinxin Chen; Jingyan Ge; Zhonghui Liu
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

7.  YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.

Authors:  Zhaoping Qin; Wei Xia; Gary J Fisher; John J Voorhees; Taihao Quan
Journal:  Cell Commun Signal       Date:  2018-04-25       Impact factor: 5.712

8.  Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells.

Authors:  Jun-Jun Wei; Li Tang; Liang-Liang Chen; Zhen-Hua Xie; Yu Ren; Hong-Gang Qi; Jiang-Yong Lou; Guo-Bin Weng; Shu-Wei Zhang
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.